Aurobindo Pharma Ltd

Common Name
Aurobindo Pharma
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
26,015
Ticker
AUROPHARMA
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Aurobindo Pharma Ltd. is a prominent pharmaceutical company engaged in the manufacturing and marketing of a broad range of generic pharmaceuticals and active pharmaceutical ingredients (APIs). The pri...

Aurobindo Pharma Waste Data Preview

In 2023, Aurobindo Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Aurobindo Pharma's Waste Treatment Practices

In 2023, Aurobindo Pharma generated a total of 49,724 metric tonnes of waste.

Of this amount, 54.86% of Aurobindo Pharma's total waste generated was recovered through methods such as recycling, reuse, or composting, while 44.57% was disposed of through landfilling, incineration, or combustion.

Aurobindo Pharma's Waste Recovery Rate

55%

How much of Aurobindo Pharma's waste is recycled or recovered?

In 2023, Aurobindo Pharma reported a total waste generation of 49,724 metric tonnes, of which 54.86% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Aurobindo Pharma is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.

Has Aurobindo Pharma reduced its environmental waste footprint over time?

Since 2019, Aurobindo Pharma's total waste generation increased by 76.72%, including a 14.2% increase in 2023, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.

Over the same period, Aurobindo Pharma's waste recovery rate decreased by 3.88%.

Aurobindo Pharma’s Waste Recovery vs. Disposal Over Time

20222023015 k30 k45 k60 ktonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into Aurobindo Pharma’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Aurobindo Pharma generated a total of 49,724 metric tonnes of waste.

Of this amount, 45.14% of Aurobindo Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 54.86% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Aurobindo Pharma’s Hazardous vs Non-Hazardous Waste Over Time

20192020202120222023015 k30 k45 k60 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Aurobindo Pharma reduced the environmental impact of its waste?

Since 2019, Aurobindo Pharma's total waste generation increased by 76.72%, including a 14.2% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.

Over the same period, the share of hazardous waste decreased by 54.86%, yet rose by 5.14% in 2023, potentially signaling operational variability, temporary setbacks, or less effective hazardous waste mitigation in the short term.

Overall, Aurobindo Pharma's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.

Want Full Access to Aurobindo Pharma's Waste Management Dataset?
Sign Up